Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the efficacy of single agent AZD9291 compared with standard of care (SoC) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) therapy as measured by progression free survival (PFS)
Inclusion criteria
- Locally advanced or metastatic non-small cell lung cancer, not amenable to curative surgery or radiotherapy